Market LIVE
Published markets; coverage varies by country
Product profile · United States

ZERBAXA

 ·  Patent Litigation & Settlement History ↓

IngredientCEFTOLOZANE SULFATE; TAZOBACTAM SODIUM
Application typeNDA
Application206829
Product001
Dosage formPOWDER
RouteINTRAVENOUS
StrengthEQ 1GM BASE/VIAL;EQ 0.5GM BASE/VIAL
Approval date2014-12-19
Marketing statusPrescription
Status event—
ApplicantCUBIST PHARMS LLC
Product source

Current GenericRadar decision

Year2028
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typeTRUE_DS_PATENT
Anchor date2028-11-15
Patent anchor2028-11-15
Exclusivity anchor2024-12-19
Protection date2036-02-14
First Final ANDA—
Status event—

Canonical 2028-11-15; DEEP_REVIEW; latest post-anchor right 2036-02-14; Final exact ANDA link not identified; not certified generic absence.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
71292322028-05-15DS/DP/U U-1676———
———
71292322028-05-15DS/DP/U U-3360———
———
71292322028-05-15DS/DP/U U-4542———
———
71292322028-05-15DS/DP/U U-4543———
———
71292322028-05-15DS/DP/U U-4550———
———
71292322028-05-15DS/DP/U U-3361———
———
71292322028-05-15DS/DP/U U-36———
———
71292322028-05-15DS/DP/U U-4547———
———
71292322028-11-15— ————
—2028-11-15—
71292322028-11-15ORANGE_BOOK U-1676,U-3360,U-3361,U-36,U-4542,U-4543,U-4547,U-4550YNTRUE_DS
English description not available.
—2028-11-15—
100289632032-09-07U U-2565———
———
100289632032-09-07U U-2566———
———
100289632032-09-07U U-4542———
———
100289632032-09-07U U-4543———
———
97243532032-09-07U U-2566———
———
97243532032-09-07U U-4543———
———
97243532032-09-07U U-2565———
———
97243532032-09-07U U-4542———
———
100289632033-03-07— ————
—2033-03-07—
100289632033-03-07ORANGE_BOOK U-2565,U-2566,U-4542,U-4543NNU
English description not available.
—2033-03-07—
97243532033-03-07— ————
—2033-03-07—
97243532033-03-07ORANGE_BOOK U-2565,U-2566,U-4542,U-4543NNU
English description not available.
—2033-03-07—
104208412034-03-14U U-3360———
———
104208412034-03-14U U-3361———
———
104208412034-03-14U U-4547———
———
104208412034-03-14U U-4546———
———
104208412034-03-14U U-2631———
———
104208412034-03-14U U-1672———
———
112786222034-03-14U U-4543———
———
112786222034-03-14U U-3335———
———
112786222034-03-14U U-3336———
———
112786222034-03-14U U-4542———
———
89687532034-03-14U U-1673———
———
89687532034-03-14U U-3361———
———
89687532034-03-14U U-3360———
———
89687532034-03-14U U-4547———
———
89687532034-03-14U U-1672———
———
89687532034-03-14U U-4550———
———
93207402034-03-14DP ————
———
98729062034-03-14DP ————
———
89068982034-05-28DS/DP ————
———
103764962034-09-09U U-4549———
———
103764962034-09-09U U-4548———
———
103764962034-09-09U U-2610———
———
103764962034-09-09U U-2611———
———
109330532034-09-09U U-3090———
———
109330532034-09-09U U-4545———
———
109330532034-09-09U U-4544———
———
109330532034-09-09U U-3091———
———
104208412034-09-14— ————
—2034-09-14—
104208412034-09-14ORANGE_BOOK U-1672,U-2631,U-3360,U-3361,U-4546,U-4547NNU
English description not available.
—2034-09-14—
112786222034-09-14— ————
—2034-09-14—
112786222034-09-14ORANGE_BOOK U-3335,U-3336,U-4542,U-4543NNU
English description not available.
—2034-09-14—
89687532034-09-14— ————
—2034-09-14—
89687532034-09-14ORANGE_BOOK U-1672,U-1673,U-3360,U-3361,U-4547,U-4550NNU
English description not available.
—2034-09-14—
93207402034-09-14— ————
—2034-09-14—
93207402034-09-14ORANGE_BOOK —NNDP
English description not available.
—2034-09-14—
98729062034-09-14— ————
—2034-09-14—
98729062034-09-14ORANGE_BOOK —NNDP
English description not available.
—2034-09-14—
89068982034-11-28— ————
—2034-11-28—
89068982034-11-28ORANGE_BOOK —NNDP
English description not available.
—2034-11-28—
103764962035-03-09— ————
—2035-03-09—
103764962035-03-09ORANGE_BOOK U-2610,U-2611,U-4548,U-4549NNU
English description not available.
—2035-03-09—
109330532035-03-09— ————
—2035-03-09—
109330532035-03-09ORANGE_BOOK U-3090,U-3091,U-4544,U-4545NNU
English description not available.
—2035-03-09—
101251492035-08-14DP ————
———
101251492036-02-14— ————
—2036-02-14—
101251492036-02-14ORANGE_BOOK —NNDP
English description not available.
—2036-02-14—

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2014-12-192019-12-19English description not available.YY—Source
GAIN2019-12-192024-12-19English description not available.YY—Source
NPP2022-04-212025-04-21English description not available.NN—Source
NPP—2029-05-12————Source
NPP2026-05-122029-05-12English description not available.NN—Source
PED—2029-11-12————Source
PED2029-05-122029-11-12English description not available.NN—Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (18)
TypeDateRoleBasisSource
PATENT2028-11-15CANONICAL_ANCHOREnglish description not available.Source
PATENT2033-03-07FTO_TAILEnglish description not available.Source
PATENT2033-03-07FTO_TAILEnglish description not available.Source
PATENT2034-09-14FTO_TAILEnglish description not available.Source
PATENT2034-09-14FTO_TAILEnglish description not available.Source
PATENT2034-09-14FTO_TAILEnglish description not available.Source
PATENT2034-09-14FTO_TAILEnglish description not available.Source
PATENT2034-09-14FTO_TAILEnglish description not available.Source
PATENT2034-11-28FTO_TAILEnglish description not available.Source
PATENT2035-03-09FTO_TAILEnglish description not available.Source
PATENT2035-03-09FTO_TAILEnglish description not available.Source
PATENT2036-02-14FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—HISTORICAL_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—HISTORICAL_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—HISTORICAL_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—FTO_TAILEnglish description not available.Source
REGULATORY_STATUS2028-11-15CANONICAL_DECISIONCanonical 2028-11-15; DEEP_REVIEW; latest post-anchor right 2036-02-14; Final exact ANDA link not identified; not certified generic absence.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.